The best indicator for Aptiv (APTV)
We backtested 366 indicators across daily, weekly and hourly charts on real Aptiv (APTV) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
FRAMA 10/30 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Aptiv (APTV) over ~14.5 years — beating buy-and-hold by 1.9% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Aptiv (APTV) — trailing buy-and-hold by 7.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Vegas Tunnel | Daily | 10.2% | 0.63 | -31.7% | 43.8% | 32 | -0.2% |
| 2 | TRIMA 200 Trend | Daily | 10.4% | 0.61 | -36.7% | 50.0% | 28 | -0.0% |
| 3 | FRAMA 10/30 Cross ✓ | Daily | 12.3% | 0.6 | -41.7% | 52.6% | 266 | 1.9% |
| 4 | ROC (5) | Weekly | 11.5% | 0.6 | -37.8% | 43.8% | 73 | 1.1% |
| 5 | KAMA 30 Trend ✓ | Daily | 11.4% | 0.58 | -43.8% | 42.7% | 143 | 1.0% |
| 6 | Trend Magic | Weekly | 11.6% | 0.58 | -58.6% | 41.0% | 39 | 1.2% |
| 7 | EMA 9/26 Cross | Daily | 11.1% | 0.57 | -49.3% | 52.5% | 59 | 0.7% |
| 8 | Elastic VW MA | Weekly | 11.1% | 0.57 | -39.5% | 46.9% | 32 | 0.7% |
| 9 | EMA 10/40 Cross | Daily | 10.8% | 0.56 | -51.2% | 43.2% | 44 | 0.4% |
| 10 | Hammer ✓ | Weekly | 6.5% | 0.56 | -30.5% | 68.4% | 19 | -4.0% |
| 11 | Supertrend (14,4) | Daily | 10.8% | 0.55 | -63.7% | 55.9% | 34 | 0.4% |
| 12 | McGinley 30 Trend | Daily | 11.7% | 0.55 | -59.2% | 36.8% | 114 | 1.3% |
| 13 | Gator Oscillator | Weekly | 5.5% | 0.55 | -27.7% | 54.9% | 51 | -4.9% |
| 14 | Vertical Horizontal Filter | Weekly | 6.6% | 0.54 | -16.3% | 57.7% | 26 | -3.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Aptiv (APTV), FRAMA 10/30 Cross on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.